Perceptive Advisors LLC Aldeyra Therapeutics, Inc. Transaction History
Perceptive Advisors LLC
- $2.28 Billion
- Q2 2025
A detailed history of Perceptive Advisors LLC transactions in Aldeyra Therapeutics, Inc. stock. As of the latest transaction made, Perceptive Advisors LLC holds 4,051,631 shares of ALDX stock, worth $21.7 Million. This represents 0.68% of its overall portfolio holdings.
Number of Shares
4,051,631
Previous 9,275,851
56.32%
Holding current value
$21.7 Million
Previous $53.3 Million
70.91%
% of portfolio
0.68%
Previous 2.23%
Shares
8 transactions
Others Institutions Holding ALDX
# of Institutions
135Shares Held
34.9MCall Options Held
244KPut Options Held
51.6K-
Knoll Capital Management, LLC Miami, FL5.48MShares$29.3 Million14.27% of portfolio
-
Black Rock Inc. New York, NY3.62MShares$19.4 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.5MShares$18.8 Million0.0% of portfolio
-
Ardsley Advisory Partners LP Stamford, CT2.05MShares$11 Million1.29% of portfolio
-
Aqr Capital Management LLC Greenwich, CT1.47MShares$7.9 Million0.0% of portfolio
About Aldeyra Therapeutics, Inc.
- Ticker ALDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 58,323,100
- Market Cap $313M
- Description
- Aldeyra Therapeutics, Inc., a biotechnology company, develops and commercializes medicines for immune-mediated ocular and systemic diseases. The company's lead product candidate is reproxalap, a reactive aldehyde species (RASP)modulator, which is in Phase III clinical trial for the treatment of dry eye diseases and allergic conjunctivitis. It al...